Cardiff Lexington

CDIX · OTC

$0.02−$0.015 (−42.86%)TodayMarket closed ·
Prev close $0.035

About CDIX

Cardiff Lexington Corp. is a holding company, which engages in capitalization and management of private enterprises. The company is headquartered in Las Vegas, Nevada and currently employs 15 full-time employees. The company went IPO on 2004-07-16. The Company’s subsidiaries include Nova Ortho and Spine, LLC (Nova) and Edge View Properties, Inc. (Edge View). Its healthcare segment provides a full range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. Its real estate segment consists of Edge View, a real estate company that owns five acres zoned medium density residential with 12 lots already platted, six acres zoned high-density residential that can be platted in various configurations to meet current housing needs, and twelve acres zoned in Lemhi County as Agriculture that is available for further annexation into the City of Salmon for development, as well as a common area for landowners to view wildlife, provide access to the Salmon River and fishing in a two acre pond.

Employees
15
Headquarters
Las Vegas, Nevada
Listed
Jul 16, 2004
Sector
Health Care
Industry
Health Care Providers & Services

Leadership

Cardiff Lexington executives
NameTitleSince
Alex Cunningham—2015
Matthew Shafer——
Gillard Johnson——
Cathy Pennington——
L. Jack Staley——

Revenue by product and region

Fiscal year ended Dec 31, 2022: $12.00M total revenue

By product

  • Healthcare Segment [Member]$10.69M89.1%
  • Financial Service [Member]$1.31M10.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.